Overview
Exploring Advances in Primary Immunodeficiencies: Expert Interview
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This activity aims to increase the knowledge and competence of immunologists, allergists, primary care providers and other clinicians involved in the management of patients with primary immunodeficiencies (PI). Differences in how clinicians manage patients with primary immunodeficiencies underscore areas where improved educational and training initiatives may benefit patient care.
In this activity, expert faculty Richard L. Wasserman, MD, PhD provides brief, one-two minute overviews of screening procedures, diagnosis, and management considerations for patients with PI. The activity features a set of short, effective, and connected lessons that affords clinicians the opportunity to absorb relevant clinical information without the need to devote significant time to learning.
In this activity, expert faculty Richard L. Wasserman, MD, PhD provides brief, one-two minute overviews of screening procedures, diagnosis, and management considerations for patients with PI. The activity features a set of short, effective, and connected lessons that affords clinicians the opportunity to absorb relevant clinical information without the need to devote significant time to learning.
This activity is designed to meet the educational needs of immunologists, allergists, primary care providers and other clinicians involved in the management of patients with primary immunodeficiencies.
Upon completing this activity, participants will be able to:
• Identify patients who are at risk for PI through patient history and appropriate laboratory studies
• Develop individualized IG administration treatment plans for patients with PI taking into consideration their clinical needs and frequency preferences
• Participate in shared decision making to enhance patient outcomes
• Identify patients who are at risk for PI through patient history and appropriate laboratory studies
• Develop individualized IG administration treatment plans for patients with PI taking into consideration their clinical needs and frequency preferences
• Participate in shared decision making to enhance patient outcomes
This activity is supported by an educational grant from Baxalta-Shire.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem while viewing any media (audio/video).
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
5. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
6. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
5. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
6. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Richard L. Wasserman, MD, PhD
Medical Director of Pediatric Allergy and Immunology, Medical City Children’s Hospital
Managing Partner, Allergy Partners of North Texas
Dallas, TX
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.
The following financial relationships have been provided:
Richard L. Wasserman, MD, PhD
Consultant: Grifols, Prometic, Therapure
Investigator/Consultant: ADMA Biologics, Bioplasma Laboratories
Investigator/Consultant/Speaker: CSL Behring
Investigator/Consultant/Speaker/Advisory Board: Baxalta
Discussion of Off-Label, Investigational, or Experimental Drug Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 15 minutes to complete. To receive credit, participants are required to complete the pre-test, view the activity, and complete the post-test and evaluation. To receive credit, 66% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.